The average woman with a germline pathogenic variant in BRCA1/2 has a 69–72% (95% CI 61–79%) lifetime risk of developing breast cancer between the ages of 25 and 80 years old [2]. This evidence concerns the gene BRCA1 and breast carcinoma.